Global Patient Recruitment, Engagement, Technology and Trends

Part III: China's Future in Global Clinical Research

Posted by Minori Shimizu on Mon, Nov 23, 2015

Active international collaboration has facilitated the rise of the Asia Pacific region in global clinical research. In the first two parts of this blog series, we’ve discussed how Japan and South Korea – whose clinical research environments vary significantly from each other – share many common interests in their pursuit for advancing clinical R&D. The open flow of data between these countries, and their desire for expanding research, has resulted in a dynamic climate for conducting clinical trials.

Read More

Part II: Insights on the Clinical Trial Landscape of South Korea

Posted by Minori Shimizu on Thu, Nov 19, 2015

Japan has taken significant steps in establishing itself as a major player in the global clinical research community, driving the demand for more clinical trials across East Asia as a result. By officially acknowledging and seeking clinical data from the Asia Pacific region, Japan is facilitating a dialogue with one of the most powerful and capable clinical trial landscapes in the world: South Korea.

Read More

Part I: The Clinical Trial Landscape of the Asia Pacific, Japan

Posted by Aaron Fleishman on Tue, Nov 17, 2015

On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of George Clinical - CRO China as our guest contributor. With more than 20 years of experience in pharmaceutical, biotech and medical device marketing, Mr. Gregory has spent over 14 years supporting the expansion of clinical trial capabilities in Asia. He will be providing his insights over the course of a three-part blog series on the growth of clinical research across the Asia Pacific region.

Read More

Patient Centricity to Shape Discussions at DIA Japan 2015

Posted by Matt Kibby on Fri, Nov 13, 2015

We are very excited to be attending next week’s 12th Annual Meeting DIA Japan 2015, to be held at Tokyo Big Sight in Tokyo, November 15 – 17. It’s the first time that many of us based here in our U.S. headquarters will be joining our Japan team since opening our new Tokyo office over the summer. Under the theme “Medicine Development” this year’s event is set to focus on the innovative and constructive influence of patients on the enterprise of clinical R&D – a topic that’s always at the center of our work here at BBK.

Read More

Country- and Site-Level Considerations for Informed Site Selection

Posted by Jaime Cohen on Fri, Nov 6, 2015

Choosing the right countries and sites for a particular study remains one of the industry’s biggest challenges – but it doesn’t have to be. When the time comes to select sites for your clinical research study, there are many considerations that can guide your decisions to ensure the best possible outcome.

Read More

Topics: Site Selection

BIO Notifier: For the Advancement of Global Clinical Research

Posted by Jaime Cohen on Mon, Oct 26, 2015

A recent survey conducted on behalf of the National Institute for Health Research Clinical Research Network shows that 89% of people would be willing to take part in a clinical trial if they were diagnosed with a medical condition or disease. This figure has very positive implications for the enterprise of global clinical research, as patient enrollment is one of the defining aspects of its success. So why is it that half of all investigative sites under-enroll for patients, and 11% of sites fail to enroll a single patient for a clinical trial?

Read More

BBK Recognized for Creative Excellence

Posted by BBK Worldwide on Mon, Oct 19, 2015

It’s award season, and we’re proud to announce a few new wins including an Rx Club Award and three American Graphic Design Awards, all for Creative Excellence. Congrats to our marketing and creative teams!

Read More

Topics: Awards, advertising

Achieving Visibility for Your Global Patient Recruitment Campaign

Posted by Sarah Mandracchia on Fri, Oct 9, 2015

There are many variables to consider when creating an advertising campaign for your clinical research study, but among the most important is the decision of which mediums to deploy. It can be staggering to think about all of the ways in which your potential patients might learn about your clinical research opportunity, and deciding how to make your campaign most visible can be challenging.

Read More

Thoughts from London on mHealth and Better Patient Engagement

Posted by Bonnie A. Brescia on Wed, Oct 7, 2015

Following an inspiring few days at last week’s SYNERGY conference in Boston, hosted by ACRES, we’re in London at the Allan Lloyds 9th Annual Optimizing Clinical Research Summit this week to share ideas with colleagues and speak about mHealth and patient engagement.

Read More

The EMV Liability Shift and its Impact on Patient Reimbursement

Posted by Juli Greenwood on Tue, Sep 29, 2015

October 1, 2015 marks an important milestone for anyone using or accepting cards in the United States. Known as the EMV liability shift (EMV is an acronym for Europay, MasterCard, Visa), it’s a deadline that’s fueling the replacement of magnetic stripe cards for more secure, globally accepted smart chip cards in the U.S. by shifting the liability for fraudulent transactions from financial institutions to the merchants that continue to accept them. So what does all this mean for global study patient reimbursement programs?

Read More

Subscribe to Our Blog!